Angiotensin receptor blockers use and changes in frailty, muscle mass, and function indexes: Singapore Longitudinal Ageing Study-Reference-Cited by-同舟云学术

Angiotensin receptor blockers use and changes in frailty, muscle mass, and function indexes: Singapore Longitudinal Ageing Study

Published:2021-02-26 Issue:2 Volume:4 Page:111-121
ISSN:2617-1619
Container-title:JCSM Rapid Communications
language:en
Short-container-title:JCSM Rapid Communications

Author:

Ng Tze Pin¹²^ORCID,Nguyen Tu N.¹,Gao Qi²,Nyunt Ma Shwe Zin²,Yap Keng Bee³,Wee Shiou‐Liang¹⁴

Affiliation:

1. Geriatric Education & Research Institute Singapore

2. Gerontology Research Programme, Department of Psychological Medicine National University of Singapore NUHS Tower Block, 9th Floor, 1E Kent Ridge Road 119228 Singapore

3. Department of Geriatric Medicine Ng Teng Fong General Hospital Singapore

4. Health and Social Sciences Cluster Singapore Institute of Technology Singapore

Funder

National Medical Research Council

Publisher

Wiley

Subject

Industrial and Manufacturing Engineering,Materials Science (miscellaneous),Business and International Management

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rco2.31

Reference44 articles.

1. Fifteen years of progress in understanding frailty and health in aging

2. Frailty in Relation to the Accumulation of Deficits

3. Frailty in Older Adults: Evidence for a Phenotype

4. Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014

5. Role of the renin–angiotensin system in age-related sarcopenia and diastolic dysfunction

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Current Landscape of Pharmacotherapies for Sarcopenia;Drugs & Aging;2024-02

2. Azilsartan prevents muscle loss and fast- to slow-twitch muscle fiber shift in natural ageing sarcopenic rats;CAN J PHYSIOL PHARM;2024

3. Azilsartan Prevents Muscle Loss and Fast to Slow-twitch Muscle Fibre Shift in Natural Ageing Sarcopenic Rats;Canadian Journal of Physiology and Pharmacology;2023-12-20

4. ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trial;PLOS ONE;2023-10-20

5. A Comprehensive Review of Essential Aspects of Molecular Pathophysiological Mechanisms with Emerging Interventions for Sarcopenia in Older People;Current Molecular Pharmacology;2023-10-06